Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas

American Journal of Surgery

Volumn 207, Issue 5, 2014, Pages 702-707

  White, Ian ^a   Fortino, Jeanine ^a   Curti, Brendan ^b   Vetto, John ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PROVIDENCE PORTLAND MEDICAL CENTER   (United States)

Author keywords

Melanoma; Sentinel lymph node biopsy; Thick

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CUTANEOUS MELANOMA; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MITOSIS RATE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; THICK MELANOMA;

MELANOMA; SENTINEL LYMPH NODE BIOPSY; THICK;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84899720073     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.12.022     Document Type: Article

References (20)

1. C.M. Balch, J.E. Gershenwald, and S.J. Soong et al. Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
2. C.M. Balch Surgical management of regional lymph nodes in cutaneous melanoma J Am Acad Dermatol 3 1980 511 524
3. S.R. Martinez, D.R. Shah, and A.D. Yang et al. Sentinel lymph node biopsy in patients with thick primary cutaneous melanoma: patterns of use and underuse utilizing a population-based model ISRN Dermatol 2013 2013 315609
4. S.L. Wong, C.M. Balch, and P. Hurley et al. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline Ann Surg Oncol 19 2012 3313 3324
5. D.G. Coit, R. Andtbacka, and C.J. Anker et al. Melanoma J Natl Compr Canc Netw 10 2012 366 400
6. D.G. Coit, R. Andtbacka, and C.J. Anker et al. Melanoma, version 2.2013: featured updates to the NCCN guidelines J Natl Compr Canc Netw 11 2013 395 407
7. D.L. Morton, A.J. Cochran, and J.F. Thompson et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial Ann Surg 242 2005 302 311 discussion, 311-3
8. J.E. Gershenwald, P.F. Mansfield, and J.E. Lee et al. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma Ann Surg Oncol 7 2000 160 165
9. C.R. Ferrone, K.S. Panageas, and K. Busam et al. Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status Ann Surg Oncol 9 2002 637 645
10. B.S. Cherpelis, F. Haddad, and J. Messina et al. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas J Am Acad Dermatol 44 2001 762 766
11. C. Gajdos, K.A. Griffith, and S.L. Wong et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer 115 2009 5752 5760
12. N.G. Fairbairn, G. Orfaniotis, and M. Butterworth Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience J Plast Reconstr Aesthet Surg 65 2012 1396 1402
13. Y. Fujisawa, and F. Otsuka The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients Melanoma Res 22 2012 362 367
14. M.C. Ellis, R. Weerasinghe, and C.L. Corless et al. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes Am J Surg 199 2010 663 668
15. F. Amersi, and D.L. Morton The role of sentinel lymph node biopsy in the management of melanoma Adv Surg 41 2007 241 256
16. D.L. Rousseau Jr., M.I. Ross, and M.M. Johnson et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients Ann Surg Oncol 10 2003 569 574
17. F. Rondelli, M.C. Vedovati, and C. Becattini et al. Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis J Eur Acad Dermatol Venereol 26 2012 560 565
18. T. Hinz, H. Ahmadzadehfar, and A. Wierzbicki et al. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution Eur J Nucl Med Mol Imaging 39 2012 1316 1325
19. C.M. Balch, T.M. Murad, and S.J. Soong et al. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods Ann Surg 188 1978 732 742
20. M.G. Rughani, M.C. Swan, and T.S. Adams et al. Sentinel node status predicts survival in thick melanomas: the Oxford perspective Eur J Surg Oncol 38 2012 936 942